IDD expertise Market position as the nation’s leading long-term care pharmacy focused exclusively on IDD and behavioral health creates a strong case for expanding partnerships with multi-state IDD programs, home and community-based providers, and agencies seeking specialized medication safety, packaging, and 24/7 pharmacist support.

Scale and reach Operations across 40+ states and a growing enterprise footprint (including recent acquisition) indicate capacity to onboard new clients, support multi-state contracts, and leverage cross-state compliance and eMAR integration to streamline client operations.

Acquisition momentum Recent acquisition by Carlyle and the 2024 Greater Boston Long Term Care acquisition signal aggressive growth and potential for expanded product offerings, bundled services, and larger multi-site contracts that sales teams can pursue with enterprise providers.

Tech enabled Utilization of analytics and digital tools (Alteryx, Tableau, iCIMS, eMAR integration, Microsoft Teams) supports data-driven care, compliance, and efficient client onboarding, which can be marketed as a value proposition to reduce risk and improve medication safety.

Strategic partnerships Exclusive focus on IDD and behavioral health creates differentiators for hospitals, home health networks, and state programs seeking specialized pharmacy partners, offering a path to targeted pilots, RFPs, and preferred-provider arrangements.